Alimera Sciences Inc.

Market cap: $187,428,931

Exchange: NAS

Sector: Health Technology

Alimera Sciences, Inc. engages in the research and development of biopharmaceutical products. It operates through the U.S. and International geographic segments. The firm focuses on the development of ophthalmic pharmaceuticals for the treatment of diabetic macular edema, wet and dry age-related macular degeneration, and retinal vein occlusion. Its products include ILUVIEN and NADPH Oxidase Inhibitors. The company was founded by Daniel C. Myers and David R. Holland on June 4, 2003 and is headquartered in Alpharetta, GA.

STOCK PRICE CHART

Key Statistics

Company Name

Alimera Sciences Inc.

Average Volume (10 days)

41,788

Average Volume (30 days)

62,335

Moving Average (50 days)

$3.83

Moving Average (200 days)

$3.6

Ex-Divided Date

n/a

Dividend Yield

P/E Ratio

Market Cap

187,428,931

Shares Outstanding

52,354,450

52-Week High Split Adjust Only

4.38

52-Week Low Split Adjust Only

1.56

Employee Count

487

Beta

0.7431

Next Earnings Date

2024-05-15

TTM Dividend Rate Per Share

Price Changes

Past 5 days

-0.06%

Past 30 days

-0.15%

Past 3 months

-0.08%

Past 6 months

0.19%

Past year

0.7%

Past 2 years

-0.42%

Past 5 years

-0.77%

Max % Change

-0.98%

PEER GROUP COMPARATIVE PERFORMANCE

Name	Ticker	Price/Sales (ttm)	Price/Book (ttm)	Forward P/E	PEG Ratio	EV/Revenue
Alimera Sciences Inc.	ALIM	n/a	n/a	55.3	n/a	n/a
Peer Avg	N/A	5.22	4.25	-1.0	5.22	5.15
Regeneron Pharmaceuticals, Inc.	REGN	5.72	4.39	10.7	5.72	5.63
Insmed Inc	INSM	15.18	12.63	-7.1	15.18	14.98
Aldeyra Therapeutics Inc	ALDX	n/a	n/a	-3.1	n/a	n/a
T2 Biosystems Inc	TTOO	n/a	n/a	-4.4	n/a	n/a